InfuSystem Holdings Inc (NYSEAMERICAN:INFU) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 21,300 shares, an increase of 12.7% from the January 15th total of 18,900 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 49,700 shares, the days-to-cover ratio is currently 0.4 days.
A number of hedge funds have recently made changes to their positions in INFU. Gabelli Funds LLC increased its position in shares of InfuSystem by 4.3% in the third quarter. Gabelli Funds LLC now owns 360,000 shares of the medical instruments supplier’s stock valued at $1,904,000 after buying an additional 15,000 shares in the last quarter. Credit Suisse AG purchased a new stake in shares of InfuSystem in the fourth quarter valued at approximately $264,000. Renaissance Technologies LLC increased its position in shares of InfuSystem by 13.0% in the fourth quarter. Renaissance Technologies LLC now owns 377,503 shares of the medical instruments supplier’s stock valued at $3,220,000 after buying an additional 43,550 shares in the last quarter. Punch & Associates Investment Management Inc. increased its position in shares of InfuSystem by 1.9% in the fourth quarter. Punch & Associates Investment Management Inc. now owns 80,500 shares of the medical instruments supplier’s stock valued at $687,000 after buying an additional 1,500 shares in the last quarter. Finally, FMR LLC purchased a new stake in shares of InfuSystem in the fourth quarter valued at approximately $675,000.
Shares of INFU stock opened at $11.01 on Friday. InfuSystem has a twelve month low of $3.90 and a twelve month high of $11.30.
InfuSystem (NYSEAMERICAN:INFU) last announced its quarterly earnings results on Wednesday, November 13th. The medical instruments supplier reported $0.05 earnings per share for the quarter. The company had revenue of $21.49 million for the quarter.
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Featured Article: Stock Symbol
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.